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Abstract 
Identifying patient characteristics that influence the rate of colorectal polyp recurrence can provide important insights 
into which patients are at higher risk for recurrence. We used natural language processing to extract polyp 
morphological characteristics from 953 polyp-presenting patients’ electronic medical records. We used subsequent 
colonoscopy reports to examine how the time to polyp recurrence (731 patients experienced recurrence) is influenced 
by these characteristics as well as anthropometric features using Kaplan-Meier curves, Cox proportional hazards 
modeling, and random survival forest models. We found that the rate of recurrence differed significantly by polyp size, 
number, and location and patient smoking status. Additionally, right-sided colon polyps increased recurrence risk by 
30% compared to left-sided polyps. History of tobacco use increased polyp recurrence risk by 20% compared to 
never-users. A random survival forest model showed an AUC of 0.65 and identified several other predictive variables, 
which can inform development of personalized polyp surveillance plans. 
Introduction 
Colorectal cancer (CRC) is the third most common cancer in the United States, killing over 50,000 individuals each 
year 1. CRC often develops from adenomas, polyps arising from glandular epithelial tissue 2. Accumulation of genetic 
and epigenetic mutations in these adenomas can result in CRC progression 3. CRC can also arise from hyperplastic 
polyps, which previously had been thought of as benign lesions 4. Surveillance of the colorectal region via 
colonoscopies has proved extremely successful in preventing CRC, as polyps can be removed before they turn 
cancerous 5. Depending on the size, number, and histology of polyps, various surveillance plans are routinely 
recommended 6.  
Previous studies have examined time-to-death for patients with CRC 7,8. However, the relationship between 
precancerous polyps and time to subsequent polyp development in the context of multiple relevant risk factors has not 
been comprehensively modeled, despite the fact that polyp recurrence is quite common. The associated rates of 
recurrence within the 1-, 3-, and 5-year surveillance periods are 10.9%, 38.2%, and 52.5%, respectively 9. While polyp 
recurrence is common, the fact that patients experience it at different rates, including some who do not develop 
subsequent polyps at all, suggests the existence of risk factors that influence susceptibility to polyp recurrence. This 
differential susceptibility motivates investigation into how individual traits and characteristics influence the rate of 
polyp recurrence. Variables linked previously to greater chances of recurrent polyps include the number of polyps at 
baseline 10, polyp size 11, polyp location 12, and gender 13.  
Time-to-event analysis, also known as survival analysis, is one useful approach to understanding the influence of 
various factors on the amount of time that elapses before the occurrence of a certain event (polyp recurrence, in this 
case), and can aid in determining which factors drive those differences 14. Although time-to-event analysis has been 
performed previously in the context of colorectal polyp recurrence 9,15, patient-level predictive modeling was not 
performed, nor were specific risk factors described. Another study 10 performed basic predictive modeling with 
physician-curated records, but did not consider free-text medical records and colonoscopy reports, which may contain 
a wealth of additional information that could be potentially useful in modeling the factors that drive polyp recurrence. 
In this study, we focused on identifying variables that influence the risk of polyp recurrence by using demographic 
and clinical information obtained from electronic medical records (EMR), as well as polyp characteristics 
automatically extracted from colonoscopy records, to develop a natural language processing (NLP) pipeline. We 
  
expect that the integration of our findings into CRC surveillance programs could potentially improve risk assessment 
and follow-up recommendations for patients.  
Methods 
Patient cohort selection  
The colonoscopy information of 4,273 randomly selected patients who underwent colonoscopy from 2011 to 2017 
was obtained from Dartmouth-Hitchcock Medical Center (DHMC; Lebanon, NH), a tertiary academic care center. 
Use of human subject data was approved by Dartmouth Institutional Review Board with a waiver of informed consent. 
Of note, the patient records before this period were not available for this study due to the installation of a new EMR 
system at DHMC in 2011. This data was filtered using the following inclusion/exclusion criteria for each patient: 
1. At least one record of a polyp must exist, 
2. Records must display no evidence of colitis or Crohn’s disease (patients who are usually under intense 
surveillance), 
3. Records of two or more colonoscopies must exist, separated by at least 6 months (records that occurred less 
than 14 days after another visit were assumed faulty due to poor colon preparation).  
 
The first record containing polyp information was considered the baseline time point for that patient (t = 0) and was 
paired with the first subsequent record showing recurrence (if the patient was recurrent) or the last available record (if 
the patient was non-recurrent). These selection criteria resulted in 953 patient record pairs included for further analysis, 
while 3,320 patients (77.7% of the original dataset) were excluded for failure to meet these criteria. Of these remaining 
pairs, we observed 731 polyp recurrence events and 222 non-recurrences (76.7% recurrence rate over 6.25 years). 712 
recurrences and 214 non-recurrences had completely non-missing data for all variables considered in this study and 
were included in the final Cox proportional hazards and random survival forest models; hence, 27 patients were 
excluded due to missing data. All information except sample time and recurrence status was propagated to the 
subsequent records from the first, allowing us to predict time to recurrence from information available as of the first 
colonoscopy only. 
Extraction of polyp characteristics from EMR  
To obtain information about colorectal polyp characteristics, we developed an in-house natural language processing 
(NLP) information extraction pipeline written in Python 3.6 (Python Software Foundation, Beaverton, OR). This 
pipeline leveraged the NLTK python library 16 to mine colonoscopy reports and extract information relating to polyp 
sizes, numbers, and locations, as these polyp features have previously been found to be important in the development 
of colorectal cancer 10–12. Our NLP pipeline allowed us to completely automate the information extraction process, 
from retrieving EMRs to finalizing the variables prepared from text, without manual curation. 
First, we scanned for the presence of known colonic locations from a controlled vocabulary used by DHMC that 
included the following locations: transverse, sigmoid, ileum cecum, anus, ascending, descending, hepatic, rectum, 
ileocecal, and splenic. Additionally, both textual and digit representations of numbers were detected using a dictionary 
lookup that converts both representations to floating point variables. Whenever a number was identified, the script 
determined whether it corresponded to a size or a quantity of polyps by identifying whether units (“mm” or “cm”) 
were present alongside or closely after the number.  
We reconciled the correspondence between polyps and their features by creating lists of polyp sizes and locations in 
the order in which they were found by the parser. Both polyp location and sizes for each polyp were reported in this 
same order for the total number of polyps in each colonoscopy record. Finally, we aggregated polyp information for 
each visit by averaging polyp sizes and incrementing a master list of locations in which polyps were found during that 
visit. Because sizes were often reported as a range (minimum to maximum size for each polyp), both size bounds were 
parsed (one value was used for both bounds if only a single size value was provided). 
 
  
Incorporation of patient demographics and clinical data 
Demographics and clinical data were queried from the DHMC EMR (Epic, Verona, Wisconsin) and were merged with 
the extracted polyp information for our analysis. This data includes anthropometrics such as gender, age, body mass 
index (BMI), smoking status, marital status, race, and ethnicity. Records were excluded from the final Cox 
proportional hazards analysis in cases of missing data. Continuous variables such as age and BMI were factorized by 
using the median to demarcate lower and higher bins. For polyp location, if most polyps in a given visit were localized 
in the left colon, it would receive the “left” designation, and vice versa. The designation of “other” was conferred in 
cases where polyps did not localize to either side more. 
Model Development 
Kaplan-Meier curves were generated and log-rank tests were performed to determine the significance of each variable 
in influencing time to recurrence. Variables with log-rank p < 0.2 were used in generating a Cox proportional hazards 
model using the survival package in R 17. A forest plot was used to visualize the resulting risk ratios with the ggForests 
package 18. A random survival forest model was generated using the randomForestSRC package 19. As random forest 
models are adept at handling many potentially redundant features, unlike Cox proportional hazards models, all 
variables in the dataset were used in the survival random forest model 20. Because traditional Kaplan-Meier analyses 
depend on discretized factors, we created binned variables for our analysis using median and tertile partitions. Thus, 
binary (greater or less than the median) and/or factorized (tertile) versions of continuous variables such as age, height, 
number of polyps, and polyp size were created. 
Results 
We plotted Kaplan-Meier time-to-event curves to assess whether various EMR features influence time to polyp 
recurrence in our cohort, shown with a common censor time of 95% of the total time period 21. These factors include 
age, gender, BMI, height, weight, smoking status, smoking frequency, race, ethnicity, marital status, polyp count, 
polyp location, and polyp size. Of these features, size of polyps (p = 0, Fig. 1) significantly altered time to recurrence: 
with increasing size, the time to recurrence shortens.  
 
Figure 1. The time to polyp recurrence becomes shorter with increasing polyp size at the baseline screening. 
Furthermore, the number of polyps (p = 0, Fig. 2) likewise shows that having more polyps shortens the recurrence 
timeframe. Tobacco use (p = 0.056, Fig. 3) also may hasten time to recurrence. Here, the “Never” class indicates 
  
patients who have never used tobacco, while the “Used” class consists of those who have (including current and former 
regular smokers). Those who used tobacco showed significantly reduced time to polyp recurrence. Finally, polyp 
location played a significant role (p = 0.032, Fig. 4), with right colon localization coinciding with a significantly 
increased polyp recurrence rate compared to the left or other regions.  
 
Figure 2. Having more than the median number of polyps (i.e., two) at the first colonoscopy coincides with more 
rapid polyp recurrence. 
 
 
Figure 3. Tobacco use (current or past) may reduce time to polyp recurrence. 
  
 
Figure 4. Polyp time to recurrence is faster when polyps localize to the right colon. 
In additional analyses, we observed that other factors such as BMI and gender, which were previously considered to 
influence polyp recurrence or colorectal cancer, showed weak or statistically insignificant associations to polyp 
recurrence. Similarly, all other factors included in our analysis did not show significant associations with time to 
recurrence. 
All informative features according to this Kaplan-Meier time-to-event analysis with p < 0.2 (polyp number, polyp 
size, tobacco use, colon location, BMI) were used to create a Cox proportional hazards model for polyp recurrence. 
Wherever continuous versions of the same (discretized) variables existed, they were used in place of the discretized 
variants shown in the Kaplan-Meier analysis; namely, polyp number, size, and BMI. The model is overall significantly 
predictive (𝜒"(6)	= 228, p = 0), and the risk ratios with 95% confidence intervals for each risk are provided in Fig. 5. 
The recurrence risk ratio (RR) increases with increasing number of polyps (RR = 1.1; 95% CI: 1.07-1.1) and maximum 
polyp size (RR = 1.1; 95% CI: 1.07-1.1). Use of tobacco increases polyp recurrence risk by 1.2 (95% CI: 1.03-1.4) 
times that of never-users. Finally, having polyps primarily in the right colon confers 1.2 (95% CI: 1.07-1.5) times the 
risk of polyp recurrence compared to the left colon.  
  
 
Figure 5. Forest plot of risk ratios from our Cox proportional hazards model for polyp recurrence. The dashed line 
represents the reference (baseline) risk ratio of 1.0 (no increase or decrease in risk).  
We also produced a random survival forest model to predict time to polyp recurrence. A random survival forest model 
is a modification of traditional random forest models using a set of survival-tree-specific splitting functions (based on 
default log rank splitting rule 22), prediction objectives (cumulative hazard function), and evaluation criteria (Harrell’s 
Concordance error rate for out-of-bag/OOB error estimation) 19. The model was generated with 1,000 trees and all 
variables mentioned above, including both continuous and discretized versions of the same variables when applicable, 
for a total of 37 predictors. The random survival forest model produced an out-of-bag error rate of 28.48% for the 
whole time period, as well as an area under the curve (AUC) score of 0.65 (Fig. 6) when computed at a prediction 
timepoint of 1,500 days. The prediction timepoint of 1,500 days was chosen as the ground truth for the AUC 
calculation as there is fairly clear separation in the plotted survival curves around this period. The most important 
features reported by the model are shown in Fig. 7. 
  
 
Figure 6. The receiver operator characteristic (ROC) curve for the random survival forest model predictions at 1,500 
days from initial polyp detection shows an AUC of 0.65. True positive rates (TPR) are shown on the y-axis and false 
positive rates (FPR) on the x-axis.  
 
 
Figure 7. Variable importance scores shown are the log10 of the absolute value of the random survival forest model 
importance weights. Polyp features (size, number, location) and BMI dominate the listing. 
  
Discussion 
We analyzed EMR records of polyp information and applied time-to-event analysis to characterize polyp recurrence. 
Kaplan-Meier curves, Cox proportional hazards models, and random survival forest models were explored in order to 
demonstrate the effects of polyp characteristics, patient demographics, and clinical information on the rate of polyp 
recurrence. We found features associated with decreased time to polyp recurrence that may prove to be important in 
tailoring patient surveillance plans based on patient health data and initial colonoscopy results.  
In particular, polyp size and number were found to be important for increasing the risk of polyp recurrence. This 
finding is consistent with previous studies, including the current colonoscopy surveillance guidelines 6 which suggest 
that greater size 23 and increased number of polyps 24 correspond to polyps at a heightened risk of developing into 
cancer. One possible explanation for this association is that the probability of deleterious mutations arising may 
increase with polyp size. Another potential hypothesis is that the increased volume of polyp tissue serves as a 
biomarker for high underlying mutation burden in the surrounding tissue. In addition to polyp size and number, 
tobacco use was also associated with differential time to polyp recurrence. Tobacco use has previously been linked to 
development of hyperplastic polyps 25, despite being found to be of only marginal significance in a previous study 10. 
Furthermore, smoking has been linked to both the greater presence of distal versus proximal adenomas as well as to 
increasing multiple versus single adenomas 26. Interestingly, the latter association may to some extent be driving the 
increased polyp number mentioned previously.  
Notably, the general colonic location of the polyps recovered in the initial colonoscopy was found to be a significant 
predictor of polyp recurrence, with polyps located in the right colon predisposing patients to higher recurrence risk. 
The histological features of the two sides are known to differ at a molecular level 27, and there are previous reports of 
poorer prognosis for patients diagnosed with right-colon CRC 28, which the authors attribute to potential increased 
mutation burden in the more ileocecal-proximal colon (classically, the right colon). It can be inferred that a higher risk 
of polyp recurrence in the region is consistent with the comparative aggressiveness of right-sided CRC. The increased 
recurrence rate in the right colon, however, might be confounded by left-sided polyps being easier to detect due to 
their polypoid morphology 29. 
To enable group comparisons in the Kaplan-Meier analyses, some categorical variables were generated from 
continuous variables (e.g., BMI, polyp size, and number). However, the reduction in dynamic range when discretizing 
continuous variables may lead to inferior performance in models capable of utilizing continuous variables, such as the 
Cox proportional hazards model and the random survival forest model. We found that swapping in the continuous 
versions of the discretized variables that were shown to be significant with the survival curve analysis produced more 
significant coefficients in the Cox proportional hazards model. Hence, consistent with intuition, the continuous 
versions of variables considered in this study tend to be more informative than their discretized counterparts. 
The random survival forest model AUC score of 0.65 and the reasonably low out-of-bag (OOB) error rate of 28.48% 
are indicative of promising predictive model performance. Comparatively, an AUC score of 0.5 denotes performance 
of a random model, much like an OOB error rate of 50% in the case of random survival forest models 19. Unlike AUC 
calculation, the OOB error rate in random survival forest models is derived from Harrell’s concordance index 29, and 
thus is not dependent on specifying a prediction timepoint 19. Interestingly, BMI performed as a strong predictor in 
the random survival forest model in comparison to the Cox proportional hazards model and survival curve analysis. 
This may be due to the complementary role of BMI information in relation to other covariates which were held out of 
the simpler models but included in the random survival forest model. 
Overall, our analysis shows time-to-event (or “survival”) analysis is a powerful technique for elucidating the factors 
that drive polyp recurrence. Notably, use of NLP afforded extraction of polyp size, number, and location from 
colonoscopy records and these were critical in differentiating and predicting time to recurrence. Because polyp 
recurrence is an important risk factor for the emergence of colorectal cancer, this analysis may have implications for 
CRC diagnosis as well. Some of the most significantly associated factors discovered by this analysis are consistent 
with previous work, but are further extended in this paper to introduce clinically relevant risk ratios and predictive 
models. As a result, this analysis can be useful for establishing a patient-specific risk of polyp recurrence. Additionally, 
using the proposed predictive machine learning model, we can estimate time to recurrence based on patient clinical 
data and polyp characteristics available from the initial colonoscopy. Such a model can usher in a precision-medicine-
based approach for personalizing CRC surveillance plans.  
  
Importantly, our time-to-event analysis pipeline with EMR data extends to predicting other outcomes such as CRC 
itself and even other cancers and cancer precursors. For example, the risk of breast cancer is known to increase by at 
least four-fold in the presence of high-risk breast lesions such as atypical ductal hyperplasia and atypical lobular 
hyperplasia 31. It is feasible to extend the current pipeline to prediction of time to developing new cases of high-risk 
lesions given patient factors such as age, hormonal molecular subtype, and other characteristics derived from patient 
medical records. One strong advantage of using NLP to analyze EMR is that this allows extraction of any predictors 
contained in these records as opposed to being limited to only curated, structured data.  
There are some limitations in the presented study. First, edge cases are possible in our dataset where the first record 
containing polyp information is not the first true incident. In these cases, this information would be recorded in other 
EMR systems at other institutions. To mitigate this risk, we plan to collaborate with a state-level colonoscopy data 
registry for a more comprehensive data collection and to makes these occurrences less likely. In addition, there might 
be cases where a recurrent polyp was not truly new but was instead an existing polyp that was missed in the previous 
colonoscopy. In the current study, we cannot separate these two cases, but we do require that all patients have a 
baseline polyp in our patient inclusion/exclusion criteria. 
Refinement of our models with data from more patients outside of a single medical institution may further improve 
predictive performance as well as generalizability. This may be particularly salient in the present case where over 76% 
of patients experienced polyp recurrence in the 6.25 years of data available, a higher number than previously reported 
elsewhere 9. Practically, for the collection of this particular type of data in the future, the inclusion of structured polyp 
information fields in medical records would dramatically reduce errors associated with NLP of unstructured text. 
Ultimately, it is our goal to enable the optimization of colonoscopy administration through a paradigm in which the 
frequency of each patient’s follow-ups is determined according to that patient’s predicted time to polyp recurrence. 
Achieving this goal, which we will pursue in future work, may allow physicians to spare low-risk patients unneeded 
colonoscopies while more aggressively monitoring patients at greater risk of rapid polyp recurrence.  
Conclusion 
In closing, our study evaluated how morphological characteristics of colorectal polyps influenced the rate of polyp 
recurrence. We found that polyp size, number, location, and patient smoking status correlated significantly with the 
recurrence rate. Moreover, colon polyps on the right-side increase recurrence risk by 30% compared to polyps on the 
left-side, and a history of tobacco use increased recurrence risk by 20% compared with never-users. Finally, we trained 
a random survival forest model for predicting survival that achieved an AUC of 0.65 and identified other predictive 
characteristics that could be helpful for developing personalized polyp surveillance plans. 
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